https://crstodayeurope.com/news/low-carbohydrate-diet-may-be-associated-with-lower-risk-of-blinding-eye-disease-2/2478047/daily0.7https://crstodayeurope.com/news/norlase-announces-ce-mark-approval-for-leaf-green-laser/2478045/daily0.7https://crstodayeurope.com/news/oxford-astrazeneca-covid-vaccine-study-shows-dual-immune-action/2478042/daily0.7https://crstodayeurope.com/news/synairgens-inhaled-interferon-beta-cuts-chance-of-developing-severe-covid-19-disease/2478043/daily0.7https://crstodayeurope.com/news/house-telehealth-leaders-move-to-cement-regulatory-changes-for-virtual-care/2478044/daily0.7https://crstodayeurope.com/news/appeals-court-rules-hhs-has-authority-to-implement-site-neutral-payments-dealing-blow-to-hospitals/2478041/daily0.7https://crstodayeurope.com/news/alcon-to-showcase-latest-innovations-data-at-asrs-2020-virtual-annual-meeting/2478040/daily0.7https://crstodayeurope.com/news/jj-eyes-late-stage-study-start-of-covid-19-vaccine-in-september/2478037/daily0.7https://crstodayeurope.com/news/trump-health-official-says-covid-patients-should-not-re-test-its-clogging-up-the-system/2478038/daily0.7https://crstodayeurope.com/news/current-considerations-in-safety-protocols/2478035/daily0.7https://crstodayeurope.com/news/topcon-acquires-henson-perimeter-business/2478033/daily0.7https://crstodayeurope.com/news/uk-us-canada-accuse-russia-of-hacking-virus-vaccine-trials/2478034/daily0.7https://crstodayeurope.com/news/low-carbohydrate-diet-may-be-associated-with-lower-risk-of-blinding-eye-disease/2478030/daily0.7https://crstodayeurope.com/news/tarsus-pharmaceuticals-announces-appointment-of-new-coo-and-cfo/2478029/daily0.7https://crstodayeurope.com/news/amazon-teams-with-crossover-health-to-pilot-employee-health-centers/2478026/daily0.7https://crstodayeurope.com/news/novartis-to-provide-15-drugs-at-zero-profit-for-treating-covid-19-symptoms/2478027/daily0.7https://crstodayeurope.com/news/reports-hint-at-positive-data-coming-for-astrazeneca-oxford-coronavirus-vaccine/2478028/daily0.7https://crstodayeurope.com/news/ocular-therapeutix-announces-its-first-published-physician-fee-schedule-for-administration-of-intracanalicular-inserts/2478025/daily0.7https://crstodayeurope.com/news/nicox-reports-on-enrollment-progress-in-mont-blanc-phase-3-clinical-trial-in-glaucoma/2478024/daily0.7https://crstodayeurope.com/news/covid-19-has-flipped-the-physician-job-search-to-a-sellers-market-recruiters-say/2478020/daily0.7https://crstodayeurope.com/news/trump-administration-strips-cdc-of-control-of-coronavirus-data/2478021/daily0.7https://crstodayeurope.com/news/astrazeneca-iqvia-partner-to-speed-up-studies-of-covid-19-vaccine-candidate/2478022/daily0.7https://crstodayeurope.com/news/modernas-covid-19-vaccine-candidate-induces-robust-response-in-all-patients-tested/2478023/daily0.7https://crstodayeurope.com/news/looking-out-for-you-a-message-from-ophthalmologists/2478018/daily0.7https://crstodayeurope.com/news/looking-out-for-you-a-message-from-optometrists/2478019/daily0.7https://crstodayeurope.com/news/national-glaucoma-research-foundation-survey-reveals-patients-experiences-and-concerns-during-covid-19/2478017/daily0.7https://crstodayeurope.com/news/alcon-announces-fda-approval-of-the-otc-switch-of-pataday-once-daily-relief-extra-strength/2478016/daily0.7https://crstodayeurope.com/news/sensible-medical-announces-partnership-aimed-at-restoring-confidence-for-safe-surgery-during-covid-19/2478015/daily0.7https://crstodayeurope.com/news/simuleye-bio-shield-launched/2478014/daily0.7https://crstodayeurope.com/news/corneat-visions-synthetic-cornea-approved-for-first-in-human-implantation/2478011/daily0.7https://crstodayeurope.com/news/allscripts-microsoft-strike-5-year-cloud-partnership-to-enhance-ehr-software/2478012/daily0.7https://crstodayeurope.com/news/senate-democrats-demand-25-billion-for-widespread-covid-19-vaccine-distribution/2478013/daily0.7https://crstodayeurope.com/news/arctic-vision-announces-32-million-in-series-a-to-expand-and-develop-ophthalmology-pipeline/2478009/daily0.7https://crstodayeurope.com/news/american-academy-of-ophthalmology-in-person-meeting-cancelled/2478008/daily0.7https://crstodayeurope.com/news/santen-and-ntc-release-results-of-phase-3-clinical-study-examining-7-day-fixed-dose-combination-of-levofloxacin/2478007/daily0.7https://crstodayeurope.com/news/hhs-allocates-another-4b-in-covid-19-relief-funds-to-rural-facilities-safety-net-hospitals/2478004/daily0.7https://crstodayeurope.com/news/schwind-receives-ce-mark-approval-for-the-schwind-atos-femtosecond/2478006/daily0.7https://crstodayeurope.com/news/imprimisrx-clinical-study-examines-combination-prescription-eyedrops/2478002/daily0.7https://crstodayeurope.com/news/oct-angiography-demonstrates-retinal-involvement-in-amblyopia/2478003/daily0.7https://crstodayeurope.com/news/women-in-ophthalmology-wio-2020-summer-symposium-goes-virtual/2477999/daily0.7https://crstodayeurope.com/news/biogen-boosts-gene-therapy-strategy-with-harvard-pact-focused-on-inherited-eye-disease/2477996/daily0.7https://crstodayeurope.com/news/new-1-billion-fund-aims-to-rescue-collapsing-antibiotic-pipeline/2477997/daily0.7https://crstodayeurope.com/news/nicox-partner-ocumension-completes-successful-hong-kong-ipo/2477998/daily0.7https://crstodayeurope.com/news/bd-launches-15-minute-coronavirus-antigen-test-promises-millions-in-coming-months/2477994/daily0.7https://crstodayeurope.com/news/vision-expo-west-2020-cancelled-new-virtual-offerings-planned/2477995/daily0.7https://crstodayeurope.com/news/accelmed-partners-completes-acquisition-of-tearlab/2477991/daily0.7https://crstodayeurope.com/news/coopervision-encourages-free-registration-for-focus-on-eye-health-national-summit/2477992/daily0.7https://crstodayeurope.com/news/laboratory-studies-confirm-betadine-antiseptic-products-effectiveness-against-covid-19-virus/2477989/daily0.7https://crstodayeurope.com/news/refractive-surgery-alliance-to-raise-awareness-of-global-vision-correction-month/2477990/daily0.7https://crstodayeurope.com/news/oertli-instrumente-names-new-director-of-the-board/2477983/daily0.7https://crstodayeurope.com/news/novavax-gains-1-6-billion-in-funding-for-covid-19-vaccine-candidate/2477984/daily0.7https://crstodayeurope.com/news/palatin-technologies-announces-reinitiation-of-enrollment-of-phase-2-study-with-pl9643-for-the-treatment-of-dry-eye-disease/2477985/daily0.7https://crstodayeurope.com/news/epa-approves-two-lysol-products-as-the-first-to-effectively-kill-novel-coronavirus-on-surfaces/2477986/daily0.7https://crstodayeurope.com/news/plex-pharmaceuticals-awarded-1-6-million-in-grant-funding-from-nih-to-advance-eye-drop-therapy-for-cataracts/2477987/daily0.7https://crstodayeurope.com/news/verma-covid-19-proving-the-need-for-greater-interoperability/2477988/daily0.7https://crstodayeurope.com/news/ocutrx-says-it-will-deliver-worlds-first-5g-ar-xr-medical-specific-platform-in-2021/2477980/daily0.7https://crstodayeurope.com/news/apple-was-already-developing-handwashing-sensing-before-covid-19-hit/2477981/daily0.7https://crstodayeurope.com/news/staar-surgicals-evo-viva-presbyopia-correcting-lens-receives-ce-mark-approval/2477977/daily0.7https://crstodayeurope.com/news/regeneron-kicks-off-prevention-trial-for-covid-19-antibody-cocktail/2477979/daily0.7https://crstodayeurope.com/news/santen-announces-fda-acceptance-of-premarket-approval-application-for-de-128-microshunt-for-review/2477976/daily0.7https://crstodayeurope.com/news/bethlehem-firms-spit-test-for-covid-19-is-coming-closer/2477975/daily0.7https://crstodayeurope.com/news/nova-eye-medical-acquires-molteno3-glaucoma-drainage-device-portfolio/2477974/daily0.7https://crstodayeurope.com/news/gensight-biologics-reports-sustained-efficacy-and-safety-among-lhon-patients-3-years-after-lumevoq-treatment/2477972/daily0.7https://crstodayeurope.com/news/patrick-f-williams-appointed-chief-financial-officer-of-staar-surgical/2477969/daily0.7https://crstodayeurope.com/news/gileads-veklury-gains-conditional-eu-approval-for-treatment-of-covid-19/2477970/daily0.7https://crstodayeurope.com/news/hydroxychloroquine-found-to-significantly-cut-death-rates-in-new-covid-19-study/2477971/daily0.7https://crstodayeurope.com/news/education-as-in-person-meetings-are-paused/2479513/daily0.7https://crstodayeurope.com/news/haag-streit-introduces-eyestar-900-oct-analyser/2477968/daily0.7https://crstodayeurope.com/news/sanofi-regenerons-kevzara-fails-late-stage-study-in-covid-19/2477966/daily0.7https://crstodayeurope.com/news/moderna-reiterates-july-start-for-phase-3-covid-19-vaccine-trial-following-report-of-delay/2477967/daily0.7https://crstodayeurope.com/news/american-academy-of-ophthalmology-to-launch-its-first-open-access-journal-in-early-2021/2477962/daily0.7https://crstodayeurope.com/news/quantel-medical-completes-acquisition-of-ellex/2477963/daily0.7https://crstodayeurope.com/news/hhs-covid-19-testing-reaching-capacity-at-some-labs-as-states-grapple-with-spikes/2477964/daily0.7https://crstodayeurope.com/news/global-covid-19-prevention-trial-of-hydroxychloroquine-to-resume/2477960/daily0.7https://crstodayeurope.com/news/new-initiative-encourages-the-graves-disease-community-to-focus-on-eye-health/2477957/daily0.7https://crstodayeurope.com/news/lawmakers-press-cdc-for-plan-on-distributing-covid-19-vaccine/2477958/daily0.7https://crstodayeurope.com/news/oculight-launches-us-subsidiary-ocu-lc/2477956/daily0.7https://crstodayeurope.com/news/cms-releases-number-of-people-who-signed-up-for-coverage-on-healthcare-gov-during-covid-19/2477954/daily0.7https://crstodayeurope.com/news/hospitals-in-new-covid-19-hot-spots-face-delicate-balancing-act-with-elective-surgeries/2477955/daily0.7https://crstodayeurope.com/news/remdesivir-the-first-coronavirus-drug-gets-a-price-tag/2477953/daily0.7https://crstodayeurope.com/news/nova-eye-medical-launches-to-propel-glaucoma-innovation/2477952/daily0.7https://crstodayeurope.com/news/santen-and-singapores-health-tech-start-up-plano-form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia/2477947/daily0.7https://crstodayeurope.com/news/the-vision-council-raises-38100-for-justice-initiatives/2477948/daily0.7https://crstodayeurope.com/news/ocublink-introduces-synthetic-eyeballs-for-ar-vr-testing/2477949/daily0.7https://crstodayeurope.com/news/coburn-technologies-announces-the-new-velocity-lte-spin-coating-system/2477946/daily0.7https://crstodayeurope.com/news/envision-conference-goes-virtual-this-august/2477945/daily0.7https://crstodayeurope.com/news/novartis-pulls-eu-filing-seeking-approval-of-xiidra-for-dry-eye-disease/2477942/daily0.7https://crstodayeurope.com/news/santen-and-ntc-announce-positive-outcome-of-for-ducressa-post-cataract-surgery-antibiotic-steroid-combination/2477944/daily0.7https://crstodayeurope.com/news/cms-upcoming-medicare-payment-rule-to-include-permanent-telehealth-expansions/2477941/daily0.7https://crstodayeurope.com/news/dorc-launches-new-range-of-eva-equiphaco-needles-and-sleeves/2477940/daily0.7https://crstodayeurope.com/news/2021-ascrs-annual-meeting-pushed-back-to-august/2477939/daily0.7https://crstodayeurope.com/news/cdc-director-there-are-likely-about-10-cases-of-covid-19-for-every-diagnosed-case/2477938/daily0.7https://crstodayeurope.com/news/visual-clinics-patient-flow-management-solution-aims-to-help-eye-care-clinics-operate-post-covid-19/2477935/daily0.7https://crstodayeurope.com/news/cdc-broadens-guidance-on-americans-facing-risk-of-severe-covid-19/2477936/daily0.7https://crstodayeurope.com/news/saunders-finds-life-after-allergan-on-board-at-newly-ipoed-bridgebio/2477933/daily0.7https://crstodayeurope.com/news/ama-pushes-for-federal-intervention-to-reform-prior-authorization/2477934/daily0.7https://crstodayeurope.com/news/topcon-announces-the-european-launch-of-myah-management-tool-for-myopia-and-dry-eye/2477931/daily0.7https://crstodayeurope.com/news/sight-sciences-names-new-chief-operating-officer-and-general-counsel/2477930/daily0.7https://crstodayeurope.com/news/federal-judge-rules-against-hospitals-in-clash-over-cms-price-transparency-rule/2477926/daily0.7https://crstodayeurope.com/news/leo-lens-pharma-lead-asset-ready-for-human-clinical-evaluation/2477927/daily0.7https://crstodayeurope.com/news/sanofi-sees-potential-approval-of-covid-19-vaccine-in-first-half-of-2021/2477923/daily0.7https://crstodayeurope.com/news/versant-health-debuts-new-eye-care-resource-center/2477925/daily0.7https://crstodayeurope.com/news/survey-use-of-virtual-education-soars-telemedicine-remains-a-small-percentage-of-volume/2477922/daily0.7https://crstodayeurope.com/news/visual-clinics-safe-visits-aims-to-help-eye-care-clinics-comply-with-new-post-covid-19-protocols/2477921/daily0.7https://crstodayeurope.com/news/gilead-to-begin-human-trials-for-the-inhaled-version-of-coronavirus-drug-remdesivir/2477919/daily0.7https://crstodayeurope.com/news/how-regenerons-covid-19-antibody-cocktail-cuts-the-risk-of-resistance/2477920/daily0.7https://crstodayeurope.com/news/uk-to-test-weekly-swabless-covid-19-screening-for-health-care-workers-students-and-more/2477918/daily0.7https://crstodayeurope.com/news/nih-becomes-latest-to-halt-covid-19-trial-of-hydroxychloroquine/2477917/daily0.7https://crstodayeurope.com/news/aurinia-completes-patient-enrollment-in-phase-2-3-trial-of-voclosporin-for-the-treatment-of-dry-eye/2477914/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-recevies-fda-clearance-for-catalys-cos-6-0-software-for-astigmatism-management/2477915/daily0.7https://crstodayeurope.com/news/providers-to-congress-patients-will-lose-access-to-care-without-permanent-expansion-of-telehealth/2477913/daily0.7https://crstodayeurope.com/news/viela-bio-announces-fda-approval-of-uplinza-inebilizumab-for-the-treatment-of-neuromyelitis-optica-spectrum-disorder-nmosd/2477912/daily0.7https://crstodayeurope.com/news/fah-demands-more-time-for-providers-to-repay-advance-medicare-payments-due-soon/2477909/daily0.7https://crstodayeurope.com/news/santen-and-orbis-international-join-forces-to-expand-access-to-training-for-eye-care-professionals-through-telemedicine-platform/2477910/daily0.7https://crstodayeurope.com/news/fitbit-joins-growing-list-of-companies-offering-back-to-work-health-screening-tools/2477908/daily0.7https://crstodayeurope.com/news/clearside-biomedical-announces-numerous-presentations-at-arvo-2020/2477906/daily0.7https://crstodayeurope.com/news/study-examines-firework-related-ocular-injuries-in-the-us/2477904/daily0.7https://crstodayeurope.com/news/ntc-grants-license-and-distribution-rights-in-israel-to-taro-pharmaceutical-for-ophthalmic-quinolone-antibiotic/2477905/daily0.7https://crstodayeurope.com/news/nyu-langone-names-new-chair-of-ophthalmology/2477903/daily0.7https://crstodayeurope.com/news/scientists-hail-dexamethasone-as-major-breakthrough-in-treating-covid-19/2477901/daily0.7https://crstodayeurope.com/news/covid-19-spikes-in-certain-states-spark-concerns-for-vulnerable-rural-hospitals/2477897/daily0.7https://crstodayeurope.com/news/lilly-begins-trial-of-olumiant-as-possible-coronavirus-treatment/2477899/daily0.7https://crstodayeurope.com/news/two-arvo-papers-provide-new-insights-for-contact-lens-based-myopia-management-with-children/2477900/daily0.7https://crstodayeurope.com/news/fda-revokes-emergency-use-authorization-for-chloroquine-and-hydroxychloroquine/2477896/daily0.7https://crstodayeurope.com/news/tarsus-pharmaceuticals-announces-positive-results-of-phase-2a-study-for-tp-03-to-treat-demodex-blepharitis/2477893/daily0.7https://crstodayeurope.com/news/orbis-international-launches-virtual-flying-eye-hospital-training-programs/2477894/daily0.7https://crstodayeurope.com/news/astrazeneca-to-supply-europe-up-to-400-million-covid-19-vaccine-doses/2479514/daily0.7https://crstodayeurope.com/news/coopervision-global-charity-releases-its-annual-impact-report-highlighting-achievements/2479515/daily0.7https://crstodayeurope.com/news/here-are-the-specialties-hit-hardest-by-the-covid-19-pandemic/2479516/daily0.7https://crstodayeurope.com/news/epa-orders-amazon-and-ebay-to-stop-sale-of-certain-pesticide-products-with-false-claims-of-efficacy-against-covid-19/2483625/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-presents-myopia-research-findings-reports-contact-lens-iol-and-equipment-data-at-arvo-annual-meeting/2479519/daily0.7https://crstodayeurope.com/news/modernizing-medicine-introduces-modmed-synapsys-development-platform/2479520/daily0.7https://crstodayeurope.com/news/aorn-releases-survey-results-exploring-ors-return-to-pre-covid-19-surgical-volumes/2479521/daily0.7https://crstodayeurope.com/news/us-states-sue-26-generic-drugmakers-for-alleged-price-fixing/2479522/daily0.7https://crstodayeurope.com/news/study-annual-costs-for-diagnostic-tests-up-to-25b-antibody-tests-up-to-19b/2479523/daily0.7https://crstodayeurope.com/news/five-coronavirus-treatments-in-development/2479524/daily0.7https://crstodayeurope.com/news/us-hits-2-million-coronavirus-cases-as-many-states-see-a-surge-of-patients/2477891/daily0.7https://crstodayeurope.com/news/trump-administration-pushes-for-health-care-facilities-to-reopen/2477892/daily0.7https://crstodayeurope.com/news/johnson-johnson-announces-acceleration-of-its-covid-19-vaccine-candidate/2477889/daily0.7https://crstodayeurope.com/news/some-biologics-may-be-better-than-others-for-averting-anterior-uveitis/2477890/daily0.7https://crstodayeurope.com/news/menarini-silicon-biosystems-begins-distribution-of-rapid-covid-19-antibody-test-in-north-america/2477887/daily0.7https://crstodayeurope.com/news/strategic-national-stockpile-aims-to-get-400m-syringes-by-december-for-covid-19-vaccine-officials/2477888/daily0.7https://crstodayeurope.com/news/eversight-awarded-targeted-research-grant-to-analyze-covid-19-effects-on-eye-donation/2477886/daily0.7https://crstodayeurope.com/news/study-vision-loss-influences-perception-of-sound/2477884/daily0.7https://crstodayeurope.com/news/texas-reports-two-consecutive-days-of-record-coronavirus-hospitalizations-weeks-after-reopening/2477885/daily0.7https://crstodayeurope.com/news/who-walks-back-comments-on-asymptomatic-transmission-of-coronavirus/2477883/daily0.7https://crstodayeurope.com/news/zeiss-announces-3-million-eyes-treated-with-smile/2477881/daily0.7https://crstodayeurope.com/news/oxford-biomedica-snags-manufacturing-equipment-to-ramp-up-production-of-covid-19-vaccine/2477880/daily0.7https://crstodayeurope.com/news/asymptomatic-spread-of-coronavirus-is-very-rare-who-says/2477878/daily0.7https://crstodayeurope.com/news/nurses-developed-eye-cysts-while-treating-covid-19-patients/2477879/daily0.7https://crstodayeurope.com/news/fda-revokes-authorization-for-decontaminating-and-reusing-chinese-made-n95-respirator-masks/2477876/daily0.7https://crstodayeurope.com/news/sherlock-bio-links-with-danahers-idt-to-supply-its-crispr-based-coronavirus-test/2477877/daily0.7https://crstodayeurope.com/news/american-medical-associations-new-president-a-passionate-defender-of-the-independent-physician/2477875/daily0.7https://crstodayeurope.com/news/new-york-times-hospitals-got-bailouts-and-furloughed-thousands-while-paying-ceos-millions/2477874/daily0.7https://crstodayeurope.com/news/octapharma-usa-extends-funding-for-covid-19-study-following-positive-preliminary-research-data/2477872/daily0.7https://crstodayeurope.com/news/implandata-launches-eyemate-iop-tracking-service-for-remote-monitoring-and-improved-glaucoma-care/2477870/daily0.7https://crstodayeurope.com/news/market-scope-premium-iol-volume-faces-challenges-in-rebounding-post-covid/2477871/daily0.7https://crstodayeurope.com/news/phosphorus-announces-fda-approval-of-at-home-saliva-test-for-covid-19/2477868/daily0.7https://crstodayeurope.com/news/abbvie-enters-deal-to-develop-antibody-therapeutic-for-covid-19/2477869/daily0.7https://crstodayeurope.com/news/hhs-requiring-labs-to-report-patients-race-ethnicity-with-covid-19-tests-in-effort-to-combat-disparities/2477867/daily0.7https://crstodayeurope.com/news/astrazeneca-targeting-over-2-billion-covid-19-vaccine-doses-after-latest-deals/2477865/daily0.7https://crstodayeurope.com/news/the-lancet-withdraws-controversial-hydroxychloroquine-study/2477866/daily0.7https://crstodayeurope.com/news/sightglass-vision-granted-ce-mark-for-novel-eyeglasses-that-slow-myopia-progression-in-children/2477859/daily0.7https://crstodayeurope.com/news/fauci-says-hes-cautiously-optimistic-about-moderna-covid-19-vaccine/2477860/daily0.7https://crstodayeurope.com/news/prevent-blindness-to-host-ninth-annual-focus-on-eye-health-national-summit-as-an-online-virtual-event/2477861/daily0.7https://crstodayeurope.com/news/lasik-vision-institute-tlc-laser-eye-center-operator-files-for-bankruptcy/2477856/daily0.7https://crstodayeurope.com/news/re-vana-therapeutics-raises-3-25-million-in-pre-series-a-financing/2477857/daily0.7https://crstodayeurope.com/news/cms-increases-penalties-following-nearly-26k-covid-19-nursing-home-deaths/2477852/daily0.7https://crstodayeurope.com/news/lilly-begins-worlds-first-human-study-of-antibody-to-treat-covid-19/2477853/daily0.7https://crstodayeurope.com/news/zeiss-and-microbiome-analytics-firm-perseus-biomics-establish-partnership/2477854/daily0.7https://crstodayeurope.com/news/nicox-initiates-first-phase-3-trial-of-ncx-470-in-glaucoma/2477855/daily0.7https://crstodayeurope.com/news/quest-diagnostics-self-collection-covid-19-test-kit-gets-fda-nod-for-emergency-use/2477851/daily0.7https://crstodayeurope.com/news/aao-statement-on-death-of-george-floyd-and-its-aftermath/2477850/daily0.7https://crstodayeurope.com/news/ocugen-to-discontinue-phase-3-ogvhd-trial/2477849/daily0.7https://crstodayeurope.com/news/gil-kliman-md-and-tom-frinzi-appointed-to-staar-surgical-board-of-directors/2477846/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-appoints-erin-mceachren-as-regional-vice-president-surgical-emea/2477847/daily0.7https://crstodayeurope.com/news/expert-hospitals-should-prepare-for-pent-up-demand-from-non-covid-19-patients/2477848/daily0.7https://crstodayeurope.com/news/bmc-virtual-spring-symposium-to-begin-today/2477844/daily0.7https://crstodayeurope.com/news/escrs-and-euretina-meetings-cancelled-virtual-meetings-planned/2477843/daily0.7https://crstodayeurope.com/news/roches-actemra-roactemra-paired-with-gileads-remdesivir-in-covid-19-pneumonia-study/2477839/daily0.7https://crstodayeurope.com/news/can-you-catch-covid-19-through-your-eyes/2477840/daily0.7https://crstodayeurope.com/news/here-are-6-factors-to-consider-when-reopening-practices/2477841/daily0.7https://crstodayeurope.com/news/new-alcon-program-aims-to-help-ecps-tap-into-opportunities-in-the-dry-eye-market-amid-covid-19-crisis/2477838/daily0.7https://crstodayeurope.com/news/ophthalmologist-shares-experience-implementing-drive-through-iop-checks-into-practice/2477836/daily0.7https://crstodayeurope.com/news/the-world-is-still-far-from-herd-immunity-for-coronavirus/2477837/daily0.7https://crstodayeurope.com/news/coronavirus-testing-machines-are-latest-bottleneck-in-troubled-supply-chain/2477835/daily0.7https://crstodayeurope.com/news/sonoma-pharmaceuticals-announces-new-ce-marking-for-microdacyn60-eye-care/2477833/daily0.7https://crstodayeurope.com/news/mynosys-changes-name-to-centricity-vision-names-new-leadership-team/2477834/daily0.7https://crstodayeurope.com/news/poll-medicare-advantage-members-are-taking-to-telehealth/2477831/daily0.7https://crstodayeurope.com/news/gene-therapy-program-at-penn-medicine-joins-aavcovid-vaccine-project/2477832/daily0.7https://crstodayeurope.com/news/a-new-law-in-laser-physics-could-make-eye-surgery-simpler/2477830/daily0.7https://crstodayeurope.com/news/nearly-half-of-americans-delayed-medical-care-due-to-pandemic/2477828/daily0.7https://crstodayeurope.com/news/u-s-lawmakers-unveil-bold-100-billion-plan-to-remake-nsf/2477829/daily0.7https://crstodayeurope.com/news/caren-mason-ceo-of-starr-surgical-named-to-top-50-healthcare-technology-ceos-of-2020/2477827/daily0.7https://crstodayeurope.com/news/inmed-releases-cbn-preclinical-results-in-glaucoma/2477826/daily0.7https://crstodayeurope.com/news/bausch-lomb-announces-the-launch-of-a-new-platform-of-preloaded-iols-luxsmart-and-luxgood/2477823/daily0.7https://crstodayeurope.com/news/hoya-surgical-optics-launches-ophthalmic-new-joint-venture-in-china/2477825/daily0.7https://crstodayeurope.com/news/novavax-initiates-phase-1-2-trial-of-covid-19-caccine-candidate-nvxe28091cov2373/2477822/daily0.7https://crstodayeurope.com/news/who-suspends-hydroxychloroquine-arm-in-global-covid-19-trial-amid-safety-review/2477821/daily0.7https://crstodayeurope.com/news/kala-pharmaceuticals-files-new-drug-application-to-fda-for-eysuvis-for-dry-eye-disease/2477818/daily0.7https://crstodayeurope.com/news/wha-73-covid-19-eye-health-and-iapb-statement-on-behalf-of-the-global-eye-care-sector/2477819/daily0.7https://crstodayeurope.com/news/cms-finalizes-plan-to-allow-medicare-advantage-plans-to-expand-telehealth-benefits/2477820/daily0.7https://crstodayeurope.com/news/conjunctivitis-can-be-sole-covid-19-symptom/2477817/daily0.7https://crstodayeurope.com/news/covid-19-international-perspectives/2477816/daily0.7https://crstodayeurope.com/news/genentech-longer-term-data-reinforce-safety-of-satralizumab-in-adults-and-adolescents-with-nmosd/2477813/daily0.7https://crstodayeurope.com/news/scientists-warn-cdc-testing-data-could-create-misleading-picture-of-pandemic/2477814/daily0.7https://crstodayeurope.com/news/a-new-artificial-eye-mimics-and-may-outperform-human-eyes/2477815/daily0.7https://crstodayeurope.com/news/coopervision-to-host-best-practices-to-get-you-back-to-practice-webinar-series/2477811/daily0.7https://crstodayeurope.com/news/politics-around-hydroxychloroquine-hamper-science/2477807/daily0.7https://crstodayeurope.com/news/color-gets-green-light-for-lamp-based-covid-19-screening-test/2477808/daily0.7https://crstodayeurope.com/news/verily-seeks-to-establish-new-covid-19-baseline-with-coronavirus-antibody-research-project/2477809/daily0.7https://crstodayeurope.com/news/inovio-hints-at-positive-early-phase-1-safety-data-for-covid-19-vaccine-ino-4800/2477810/daily0.7https://crstodayeurope.com/news/reopen-eyecare-website-launches-today/2477805/daily0.7https://crstodayeurope.com/news/three-states-will-use-apple-google-contact-tracing-technology-for-virus-tracking-apps/2477806/daily0.7https://crstodayeurope.com/news/covid-19-are-todays-protocols-tomorrows-routines/2477804/daily0.7https://crstodayeurope.com/news/aldeyra-therapeutics-advances-ivestigational-hsp90-inhibitor-to-clinical-testing-for-covid-19/2477799/daily0.7https://crstodayeurope.com/news/new-paper-in-clinical-and-experimental-optometry-summarizes-sars-cov-2-interaction-with-the-ocular-surface/2477800/daily0.7https://crstodayeurope.com/news/navajo-nation-surpasses-new-york-state-for-the-highest-covid-19-infection-rate-in-the-us/2477801/daily0.7https://crstodayeurope.com/news/clyraguard-shows-complete-inactivation-of-sars-cov-2-virus-in-study-at-galveston-national-lab/2477802/daily0.7https://crstodayeurope.com/news/tearclear-appoints-dr-amir-shojaei-chief-development-officer/2477803/daily0.7https://crstodayeurope.com/news/fda-gives-octapharma-usa-green-light-to-conduct-phase-3-clinical-trial-of-covid-19-treatment/2477798/daily0.7https://crstodayeurope.com/news/roche-antibody-test-for-covid-19-goes-live-at-more-than-20-initial-lab-sites-in-the-us/2477797/daily0.7https://crstodayeurope.com/news/mayo-clinic-commonspirit-and-mass-general-feel-hit-from-covid-19-in-q1/2477795/daily0.7https://crstodayeurope.com/news/market-scope-premium-iols-expected-to-drive-market-growth-over-the-next-5-years/2477796/daily0.7https://crstodayeurope.com/news/atia-vision-closes-second-tranche-of-20m-in-series-d-financing/2477793/daily0.7https://crstodayeurope.com/news/kubota-vision-introduces-electronic-eyeglasses-to-stop-myopia-in-children/2477794/daily0.7https://crstodayeurope.com/news/avellino-announces-a-c-t-s-program-to-help-eye-care-and-other-surgical-practices-protect-patients-and-staff-from-covid-19/2477792/daily0.7https://crstodayeurope.com/news/first-covid-19-vaccine-tested-in-the-us-shows-promise-in-data-from-eight-people/2477791/daily0.7https://crstodayeurope.com/news/covid-19-views-from-egypt-italy-sweden-and-the-united-states/2477790/daily0.7https://crstodayeurope.com/news/mount-sinai-launches-post-covid-19-care-center-for-ongoing-treatments-research/2477788/daily0.7https://crstodayeurope.com/news/bvi-expands-portfolio-with-new-viscoelastic-forges-strategic-partnership-with-croma/2477789/daily0.7https://crstodayeurope.com/news/coopervision-biofinity-toric-multifocal-contact-lenses-now-available-nationwide-in-the-us/2477786/daily0.7https://crstodayeurope.com/news/sight-sciences-announces-positive-clinical-results-from-trial-evaluating-tearcare-for-the-treatment-of-dry-eye-disease/2477787/daily0.7https://crstodayeurope.com/news/oculis-reports-topline-data-from-phase-2-trial-with-ocs-01-for-treating-inflammation-and-pain-following-cataract-surgery/2477782/daily0.7https://crstodayeurope.com/news/ama-issues-guidance-to-physicians-on-using-covid-19-antibody-tests/2477783/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-presents-data-showcasing-dexycu-at-the-ascrs-virtual-meeting/2477784/daily0.7https://crstodayeurope.com/news/tiny-biotech-sorrento-claims-it-has-a-coronavirus-cure/2477780/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-announces-the-us-launch-of-the-tecnis-multifocal-toric-ii-iol/2477778/daily0.7https://crstodayeurope.com/news/allergan-to-share-new-safety-and-efficacy-data-on-recently-approved-durysta-at-ascrs-virtual-meeting/2477773/daily0.7https://crstodayeurope.com/news/vsy-biotechnology-says-it-has-developed-a-new-drug-to-treat-covid-19/2477774/daily0.7https://crstodayeurope.com/news/nih-to-test-hydroxychloroquine-azithromycin-combination-as-potential-covid-19-treatment/2477775/daily0.7https://crstodayeurope.com/news/trump-administration-aims-to-replenish-strategic-national-stockpile-to-brace-for-2nd-covid-19-wave/2477777/daily0.7https://crstodayeurope.com/news/prevent-blindness-unveils-new-brand-identity-logo-and-website/2477772/daily0.7https://crstodayeurope.com/news/covid-19-and-hvac-mitigating-the-spread/2477771/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-announces-global-initiatives-to-support-eye-care-professionals-and-patients-during-covid-19-and-beyond/2477770/daily0.7https://crstodayeurope.com/news/aao-calls-on-health-plans-to-suspend-prior-authorization-and-step-therapy/2477767/daily0.7https://crstodayeurope.com/news/new-data-on-the-pharmacokinetic-profile-of-tepezza-reinforce-the-labeled-dosing-regimen/2477768/daily0.7https://crstodayeurope.com/news/labcorp-quest-broaden-availability-of-covid-19-tests-nationwide/2477766/daily0.7https://crstodayeurope.com/news/ecps-can-now-access-online-training-to-certify-to-prescribe-coopervisions-brilliant-futures-myopia-management-program/2477762/daily0.7https://crstodayeurope.com/news/the-vision-council-releases-april-covid-19-optical-impact-consumer-study/2477763/daily0.7https://crstodayeurope.com/news/regenerx-joint-venture-announces-efficacy-results-of-neurotrophic-keratopathy-phase-3-clinical-trial-with-rgn-259/2477764/daily0.7https://crstodayeurope.com/news/trump-to-name-former-glaxosmithkline-executive-to-head-warp-speed-coronavirus-vaccine-effort-reports/2477765/daily0.7https://crstodayeurope.com/news/fbi-and-dhs-warn-that-chinese-hackers-are-targeting-us-covid-research/2477761/daily0.7https://crstodayeurope.com/news/house-democrats-push-new-round-of-stimulus-checks-in-coronavirus-bill/2477760/daily0.7https://crstodayeurope.com/news/covid-19-key-technologies/2477758/daily0.7https://crstodayeurope.com/news/prof-john-m-nolan-receives-heidelberg-engineering-xtreme-research-award-2020/2477755/daily0.7https://crstodayeurope.com/news/new-visionix-vx65-digital-phoropter-helps-ecps-meet-social-distancing-recommendations/2477756/daily0.7https://crstodayeurope.com/news/gilead-inks-non-us-deals-with-five-generic-drugmakers-to-expand-supply-of-covid-19-drug-remdesivir/2477757/daily0.7https://crstodayeurope.com/news/ocular-therapeutix-announces-first-patient-dosed-in-phase-1-clinical-trial-of-otx-csi-for-treatment-of-dry-eye-disease/2477754/daily0.7https://crstodayeurope.com/news/regeneron-ceo-manufacturing-not-up-to-snuff-for-covid-19-vaccines-therapies/2477753/daily0.7https://crstodayeurope.com/news/novavax-granted-up-to-384-million-in-new-cepi-funding-for-covid-19-vaccine-candidate/2477747/daily0.7https://crstodayeurope.com/news/inmed-files-pct-patent-application-for-neuroprotection-in-glaucoma/2477748/daily0.7https://crstodayeurope.com/news/trump-administration-allocates-11b-for-covid-19-testing-as-faster-tests-get-approved/2477749/daily0.7https://crstodayeurope.com/news/regeneron-links-with-univ-of-colorado-to-sequence-450000-patients-for-drug-research/2477750/daily0.7https://crstodayeurope.com/news/stoke-therapeutics-presents-preclinical-data-on-potential-treatment-for-inherited-optic-nerve-disorder/2477751/daily0.7https://crstodayeurope.com/news/alcon-to-highlight-scientific-program-showcasing-latest-innovations-at-virtual-ascrs/2477746/daily0.7https://crstodayeurope.com/news/us-physician-survey-illustrates-the-impact-of-thyroid-eye-disease-on-patient-quality-of-life/2477745/daily0.7https://crstodayeurope.com/news/oyster-point-announces-results-of-phase-3-trial-of-oc-01-nasal-spray-for-treatment-of-signs-and-symptoms-of-dry-eye-disease/2477743/daily0.7https://crstodayeurope.com/news/tearlab-acquired-by-accelmed-partners-for-25-million/2477742/daily0.7https://crstodayeurope.com/news/niaid-launches-actt-2-trial-testing-gileads-remdesivir-plus-eli-lilly-incytes-jak-inhibitor-olumiant-in-covid-19/2477741/daily0.7https://crstodayeurope.com/news/analysis-55-percent-fewer-americans-sought-hospital-care-in-march-april-due-to-covid-19/2477738/daily0.7https://crstodayeurope.com/news/abbvie-completes-acquisition-of-allergan/2477739/daily0.7https://crstodayeurope.com/news/dyno-therapeutics-collaborates-with-novartis-to-develop-improved-gene-therapies-with-aav-vectors-based-on-ai-technology/2477740/daily0.7https://crstodayeurope.com/news/scientists-find-eye-cells-are-a-prime-target-for-covid-19-to-attach-to/2477736/daily0.7https://crstodayeurope.com/news/quidel-receives-emergency-authorization-for-rapid-antigen-covid-19-diagnostic-assay/2477735/daily0.7https://crstodayeurope.com/news/covid-19-weekly-review/2477734/daily0.7https://crstodayeurope.com/news/the-allergan-foundation-doubles-its-covid-19-response-donations-to-4-0-million/2477733/daily0.7https://crstodayeurope.com/news/doximity-enters-telemedicine-with-launch-of-dialer-video/2477732/daily0.7https://crstodayeurope.com/news/covid-19-a-global-response/2477731/daily0.7https://crstodayeurope.com/news/visual-impairment-tied-to-increased-dementia-risk-in-older-women/2477730/daily0.7https://crstodayeurope.com/news/hydroxychloroquine-fails-to-help-hospitalized-coronavirus-patients-in-us-funded-study/2477728/daily0.7https://crstodayeurope.com/news/moderna-secures-fda-approval-to-advance-coronavirus-vaccine-candidate-mrna-1273-to-phase-2-testing/2477729/daily0.7https://crstodayeurope.com/news/fight-for-sight-launches-survey-on-impact-of-covid-19-on-people-with-eye-conditions/2477726/daily0.7https://crstodayeurope.com/news/insight-into-fdas-revised-policy-on-antibody-tests-prioritizing-access-and-accuracy/2477725/daily0.7https://crstodayeurope.com/news/coopervision-offers-complimentary-contact-lenses-for-hospital-workers-on-front-lines-of-covid-19-pandemic/2477724/daily0.7https://crstodayeurope.com/news/sight-sciences-introduces-the-next-generation-omni-surgical-system-for-microinvasive-glaucoma-surgery/2477720/daily0.7https://crstodayeurope.com/news/mystery-inflammatory-syndrome-in-kids-and-teens-likely-linked-to-covid-19/2477722/daily0.7https://crstodayeurope.com/news/fda-increases-oversight-requirements-for-covid-19-antibody-tests/2477723/daily0.7https://crstodayeurope.com/news/eyexam-and-geniemd-announce-mobile-collaboration-in-eye-care/2477719/daily0.7https://crstodayeurope.com/news/covid-19-telemedicine-in-retina/2477717/daily0.7https://crstodayeurope.com/news/uk-surpasses-italy-in-recorded-coronavirus-deaths-now-leads-europe-in-fatalities/2477715/daily0.7https://crstodayeurope.com/news/three-potential-futures-for-covid-19-recurring-small-outbreaks-a-monster-wave-or-a-persistent-crisis/2477716/daily0.7https://crstodayeurope.com/news/abbvie-allergan-gain-us-antitrust-clearance-for-deal/2477714/daily0.7https://crstodayeurope.com/news/covid-19-updates-from-society-leadership/2477712/daily0.7https://crstodayeurope.com/news/pfizer-begins-human-testing-for-experimental-coronavirus-vaccine-in-the-us/2477710/daily0.7https://crstodayeurope.com/news/world-leaders-pledge-8-billion-to-fight-covid-19-us-skips-meeting/2477711/daily0.7https://crstodayeurope.com/news/build-your-online-presence/2477709/daily0.7https://crstodayeurope.com/news/massachusetts-eye-and-ear-advancing-experimental-gene-based-covid-19-vaccine-aavcovid/2477708/daily0.7https://crstodayeurope.com/news/icare-usa-new-confocal-fundus-imaging-system-and-handheld-tonometer/2477707/daily0.7https://crstodayeurope.com/news/ai-supported-test-can-detect-glaucoma-progression-18-months-earlier/2477706/daily0.7